Drug Type Small molecule drug |
Synonyms RPR209685 |
Target |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17ClN4O3S2 |
InChIKeyPLWVUIRWJVKSSD-XBXARRHUSA-N |
CAS Registry502936-46-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thromboembolism | Preclinical | US | 27 Feb 2003 |